Trial · NCT05347498
A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults
NCT05347498, Phase 1, Unknown, Jiangsu HengRui Medicine Co., Ltd.
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults. Trials, record NCT05347498. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05347498
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults
- NCT number
- NCT05347498
- Status
- Unknown
- Phases
- Phase 1
- Enrollment
- 90 participants, estimated
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Conditions
- Primary Gout With Hyperuricemia in Adults
- Interventions
- HR091506 tablets + placebo of febuxostat tablets, febuxostat tablets + placebo of HR091506 tablets
- First posted
- 2022-04-26
- Last updated
- 2022-04-26
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The proportion of subjects with serum uric acid level < 360μmol/L on Day 15. | on Day 15. | |
| Primary | Proportion of subjects with serum uric acid level < 360μmol/L at test of cure (TOC) | Test of cure, defined as the day after end of treatment, equivalent to Study Day 15 or 29 | |
| Secondary | The proportion of subjects with serum uric acid level < 300μmol/L on Day 15. | on Day 15. | |
| Secondary | Proportion of subjects with serum uric acid level < 360μmol/L at TOC | Test of cure, defined as the day after end of treatment, equivalent to Study Day 15 or 29 | |
| Secondary | The proportion of subjects with serum uric acid level < 360μmol/L on Day 29. | on Day 29. | |
| Secondary | The proportion of subjects with serum uric acid level < 300μmol/L on Day 29. | on Day 29. | |
| Secondary | Change of serum uric acid level from baseline on Day 15 | from baseline on Day 15 | |
| Secondary | Change of serum uric acid level from baseline on Day 29 | from baseline on Day 29 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05347498
GET https://conductscience.org/api/trials/v1/NCT05347498/registered